BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 33386995)

  • 1. Mesenchymal stem cell therapy in hypertrophic and keloid scars.
    Bojanic C; To K; Hatoum A; Shea J; Seah KTM; Khan W; Malata CM
    Cell Tissue Res; 2021 Mar; 383(3):915-930. PubMed ID: 33386995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laser therapy for treating hypertrophic and keloid scars.
    Leszczynski R; da Silva CA; Pinto ACPN; Kuczynski U; da Silva EM
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD011642. PubMed ID: 36161591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
    Fang F; Huang RL; Zheng Y; Liu M; Huo R
    J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Mechanisms for Prevention and Treatment of Pathological Scars with Mesenchymal Stem Cells.
    Yu LJ; Wang XJ; Long X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):573-577. PubMed ID: 28877838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silicone gel sheeting for preventing and treating hypertrophic and keloid scars.
    O'Brien L; Jones DJ
    Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD003826. PubMed ID: 24030657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights on keloids, hypertrophic scars, and striae.
    Ud-Din S; Bayat A
    Dermatol Clin; 2014 Apr; 32(2):193-209. PubMed ID: 24680006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment.
    Berman B; Maderal A; Raphael B
    Dermatol Surg; 2017 Jan; 43 Suppl 1():S3-S18. PubMed ID: 27347634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silicon gel sheeting for preventing and treating hypertrophic and keloid scars.
    O'Brien L; Pandit A
    Cochrane Database Syst Rev; 2006 Jan; (1):CD003826. PubMed ID: 16437463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keloid and hypertrophic scars: a review of recent developments in pathogenesis and management.
    Mofikoya BO; Adeyemo WL; Abdus-salam AA
    Nig Q J Hosp Med; 2007; 17(4):134-9. PubMed ID: 18320758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.
    Lee HJ; Jang YJ
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Most Current Algorithms for the Treatment and Prevention of Hypertrophic Scars and Keloids: A 2020 Update of the Algorithms Published 10 Years Ago.
    Ogawa R
    Plast Reconstr Surg; 2022 Jan; 149(1):79e-94e. PubMed ID: 34813576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-mesenchymal transition in the formation of hypertrophic scars and keloids.
    Yuan FL; Sun ZL; Feng Y; Liu SY; Du Y; Yu S; Yang ML; Lv GZ
    J Cell Physiol; 2019 Dec; 234(12):21662-21669. PubMed ID: 31106425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser.
    Alster TS; Williams CM
    Lancet; 1995 May; 345(8959):1198-200. PubMed ID: 7739306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management.
    Wolfram D; Tzankov A; Pülzl P; Piza-Katzer H
    Dermatol Surg; 2009 Feb; 35(2):171-81. PubMed ID: 19215252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.
    Gauglitz GG; Korting HC; Pavicic T; Ruzicka T; Jeschke MG
    Mol Med; 2011; 17(1-2):113-25. PubMed ID: 20927486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
    Ogawa R
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
    Ogawa R; Akaishi S
    Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Progress of Adipose-derived Stem Cells in the Therapy of Hypertrophic Scars.
    He X; Zhang J; Luo L; Shi J; Hu D
    Curr Stem Cell Res Ther; 2020; 15(1):77-85. PubMed ID: 31483236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on management of keloid and hypertrophic scars: A systemic review.
    Elsaie ML
    J Cosmet Dermatol; 2021 Sep; 20(9):2729-2738. PubMed ID: 34169622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of Silicone Gel Sheeting and Silicone Gel for the Prevention of Hypertrophic Scars and Keloids.
    Hsu KC; Luan CW; Tsai YW
    Wounds; 2017 May; 29(5):154-158. PubMed ID: 28570253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.